Elacridar

TargetMol
Product Code: TAR-T2657
Supplier: TargetMol
CodeSizePrice
TAR-T2657-5mg5mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-1mL1 mL * 10 mM (in DMSO)£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-10mg10mg£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-25mg25mg£158.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-50mg50mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-100mg100mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-200mg200mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2657-500mg500mg£707.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Elacridar (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor.
CAS:
143664-11-3
Formula:
C34H33N3O5
Molecular Weight:
563.654
Pathway:
Membrane transporter/Ion channel; Neuroscience
Purity:
0.9962
SMILES:
COc1cc2CCN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(OC)cccc4c5=O)cc3)Cc2cc1OC
Target:
BCRP; P-gp

References

1. Tang SC, et al. Int J Cancer. 2014, 134(6), 1484-1494. 2. Hyafil F, et al. Cancer Res. 1993, 53(1), 4595-4602. 3. Sato H, et al. Eur J Pharmacol. 2015, 746, 258-266. 4. Sane R, et al. Drug Metab Dispos. 2012, 40(8), 1612-1619. 5. de Vries NA, et al. Clin Cancer Res. 2007, 13(21), 6440-6449.